Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis

@article{Cipriani2016ComparativeEA,
  title={Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis},
  author={A. Cipriani and X. Zhou and C. D. Giovane and S. Hetrick and P. Xie},
  journal={The Lancet},
  year={2016},
  volume={388},
  pages={881-890}
}
  • A. Cipriani, X. Zhou, +2 authors P. Xie
  • Published 2016
  • Medicine
  • The Lancet
  • BACKGROUND Major depressive disorder is one of the most common mental disorders in children and adolescents. However, whether to use pharmacological interventions in this population and which drug should be preferred are still matters of controversy. Consequently, we aimed to compare and rank antidepressants and placebo for major depressive disorder in young people. METHODS We did a network meta-analysis to identify both direct and indirect evidence from relevant trials. We searched PubMed… CONTINUE READING
    278 Citations
    Antidepressants for depressive disorder in children and adolescents: a database of randomised controlled trials
    • 1
    Practitioner Review: Therapeutics of unipolar major depressions in adolescents.
    • I. Goodyer, P. Wilkinson
    • Psychology, Medicine
    • Journal of child psychology and psychiatry, and allied disciplines
    • 2019
    • 7
    • PDF

    References

    SHOWING 1-10 OF 60 REFERENCES
    Paroxetine versus clomipramine in adolescents with severe major depression: a double-blind, randomized, multicenter trial.
    • 69
    • Highly Influential
    Efficacy of antidepressants in juvenile depression: meta-analysis.
    • 138
    • PDF
    Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial.
    • 504
    • Highly Influential
    • PDF